Aperis - Fides Imaging

Aperis is the proprietary, web-native imaging platform at the core of Fidēs, designed to support how scientists actually interrogate imaging while studies are still evolving.

Learn more

Learn more Learn more

Most platforms move data.
Aperis supports decisions.

The standard model for imaging data management in clinical trials is transactional — data moves from site to Core Lab, a read is performed, a report is issued. That model was built for late-phase confirmatory studies where the scientific questions are already settled. In early development, the questions are not settled. Aperis was designed for that reality: a platform that gives sponsors, scientists and readers continuous access to imaging data, annotations and emerging results — not just at formal milestones, but throughout the study.

Real-Time Data Access

Sponsors and study teams access imaging data, annotations and analyses continuously — not only when formal reads are complete. Emerging signals are visible as they develop.

Collaborative Review Environment

Sponsors, imaging scientists and central readers work within a single shared environment. Fewer handoffs, less operational noise, clearer scientific conversations.

Adaptive Workflow Support

Early development requires flexibility. Aperis supports novel and additive endpoints without forcing programs into the rigid operational structures designed for late-stage trials.

Direct Sponsor Integration

Imaging data transfers directly into sponsor cloud environments via audited workflows, reducing manual handling, transcription risk and chain-of-custody complexity.

One environment.
Every stakeholder.

Aperis brings together the people who need to engage with imaging data in a single, secure workspace, removing the fragmentation that typically slows scientific progress in multi-site trials.

Multi-modality, side-by-side image review MRI, CT, ultrasound, endoscopy and complementary modalities within a single viewer, without specialist hardware.
Embedded workflows that reduce transcription errors Data entry, scoring and reporting happen within structured, validated workflows rather than across disconnected systems.
Real-time annotation and interpretation Readers annotate directly within the platform, with annotations timestamped, attributed and immediately visible to authorised stakeholders.
Direct data transfer into sponsor cloud environments Compliant, audited export pathways built in from the start, not retrofitted at study close.

Transparency is not a reporting feature. It is engineered into how we operate.

Aperis aligns data access with scientific decision points — so sponsors engage with imaging at the moments that matter, not after the window for learning has passed.

Built for studies where the protocol is still learning.

Late-stage imaging platforms are designed around fixed protocols, predetermined endpoints and minimal scientific iteration. That rigidity serves confirmatory Phase III trials. It does not serve early development, where the value of imaging is precisely its ability to inform decisions that are still open.

Aperis supports adaptive imaging workflows — including novel, additive and exploratory endpoints — without requiring programs to conform to operational structures that were not built for them. When the study design evolves, the platform evolves with it.

Discuss Your Study Discuss Your Study